Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nivolumab ipilimumab | 1.74 | 0.8 | 7180 | 61 | 22 |
nivolumab | 0.49 | 0.6 | 1886 | 52 | 9 |
0.21 | 0.2 | 4127 | 18 | 1 | |
ipilimumab | 1.33 | 0.3 | 5163 | 24 | 10 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nivolumab ipilimumab | 1.15 | 0.9 | 2318 | 70 |
nivolumab ipilimumab melanoma | 1.97 | 0.4 | 412 | 49 |
nivolumab ipilimumab nsclc | 1.4 | 0.1 | 9596 | 21 |
nivolumab ipilimumab chpl | 0.72 | 0.4 | 5221 | 38 |
nivolumab ipilimumab mesothelioma | 0.38 | 0.1 | 7879 | 9 |
nivolumab ipilimumab rcc | 1.98 | 0.8 | 8546 | 49 |
nivolumab ipilimumab renal cell carcinoma | 1.23 | 0.3 | 1430 | 49 |
nivolumab ipilimumab side effects | 1.05 | 0.2 | 1460 | 57 |
nivolumab ipilimumab cervical cancer | 1.41 | 0.9 | 3954 | 64 |
nivolumab ipilimumab hcc | 0.61 | 0.1 | 8342 | 58 |
nivolumab ipilimumab hcc first line | 0.03 | 0.7 | 5843 | 1 |
nivolumab ipilimumab lung cancer | 1.59 | 0.5 | 9205 | 35 |
nivolumab ipilimumab colorectal cancer | 1.61 | 1 | 7410 | 12 |
nivolumab ipilimumab colon msi | 1.32 | 0.4 | 8321 | 88 |
nivolumab ipilimumab hepatocellular carcinoma | 0.07 | 0.1 | 5421 | 56 |
ipilimumab and nivolumab | 0.31 | 0.6 | 9051 | 100 |
nivolumab combined with ipilimumab | 0.56 | 0.5 | 8010 | 68 |
ipilimumab and nivolumab side effects | 1.09 | 0.8 | 7241 | 95 |
nivolumab and ipilimumab therapy | 1.3 | 0.4 | 2115 | 83 |
ipilimumab + nivolumab | 1.11 | 0.5 | 6126 | 44 |